PHOTOBIOMODULATION IN NEUROLOGY AND ITS PROSPECTS FOR USE IN MYASTHENIA
Keywords:
Photobiomodulation, myasthenia gravis, low-level laser therapy, neuromuscular transmission, autoimmune diseases.Abstract
Myasthenia is a chronic autoimmune disease characterized by impaired transmission of nerve impulses to striated muscles. This condition typically presents with pronounced muscle fatigue and weakness, especially during physical exertion. Despite the availability of well-established pharmacological treatment strategies, including immunosuppressive therapy and symptomatic medications, there remains a need for additional non-pharmacological methods that can enhance the effectiveness of rehabilitation and improve patients’ quality of life. In this context, photobiomodulation (PBM) has attracted growing scientific and clinical interest. PBM is an innovative physiotherapeutic approach based on the use of low-intensity laser or LED irradiation within a specific spectral range.
References
Вейн А.М., Гусев Е.И. Неврология: Национальное руководство. — М.: ГЭОТАР-Медиа, 2022. — 816 с.
Бабаян А.А., Давидян С.А., Арутюнян И.Н. Возможности применения низкоинтенсивного лазерного излучения в клинической медицине // Вестник восстановительной медицины. — 2021. — №3. — С. 42–47.
Байтингер В.Ф., Лобанов А.А. Современные направления физиотерапии в неврологии // Журнал неврологии и психиатрии им. С.С. Корсакова. — 2020. — Т. 120, №10. — С. 85–90.
Hamblin M.R. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation // AIMS Biophysics. — 2017. — Vol. 4, No. 3. — P. 337–361. https://doi.org/10.3934/biophy.2017.3.337
Karu T.I. Mitochondrial signaling in mammalian cells activated by red and near-IR radiation // Photochem Photobiol. — 2008. — Vol. 84. — P. 1091–1099. https://doi.org/10.1111/j.1751-1097.2008.00394.x
Huang Y.Y., Sharma S.K., Carroll J.D., Hamblin M.R. Biphasic dose response in low level light therapy // Dose-Response. — 2011. — Vol. 9, No. 4. — P. 602–618. https://doi.org/10.2203/dose-response.11-027.Hamblin
Salehpour F., Cassano P., Chang M., Hamblin M.R. Near-infrared photobiomodulation in neurodegenerative diseases: a systematic review // Aging Dis. — 2020. — Vol. 11, No. 2. — P. 302–321. https://doi.org/10.14336/AD.2019.0610
Naeser M.A., Saltmarche A., Krengel M.H., et al. Improved cognitive function after transcranial LED treatments in chronic traumatic brain injury // Photomed Laser Surg. — 2011. — Vol. 29, No. 5. — P. 351–358. https://doi.org/10.1089/pho.2010.2814
Almutairi A., Mahir A., Alqurashi M. et al. Efficacy of photobiomodulation for muscle performance and recovery: a systematic review and meta-analysis // Lasers Med Sci. — 2022. — Vol. 37. — P. 1287–1301. https://doi.org/10.1007/s10103-021-03312-4
Baybekov I., Mustafakulov Kh., Rasulov F. Laser therapy and plasmapheresis in myasthenia gravis: effects on erythrocytes and endothelium // Proc. SPIE. — 2010. — Vol. 7547. — P. 75470C. https://doi.org/10.1117/12.849960
Lan C.H., Hsu S.P., Cheng M.C. Application of Intravascular Laser Irradiation of Blood in a Patient with Refractory Myasthenia Gravis: A Case Report // World J Clin Cases. — 2022. — Vol. 10, No. 6. — P. 2023–2028. https://doi.org/10.12998/wjcc.v10.i6.2023
Zhou Y., Guo M., Wang J. et al. Extracellular vesicles carrying caspase-1 inhibitors alleviate symptoms of experimental autoimmune myasthenia gravis // J Control Release. — 2023. — Vol. 360. — P. 12–25. https://doi.org/10.1016/j.jconrel.2023.05.006
Alchinova I.B., Lysenko L.A., et al. Laser correlation spectroscopy in diagnostics of myasthenia gravis // J Biomed Opt. — 2014. — Vol. 19, No. 2. — P. 021103. https://doi.org/10.1117/1.JBO.19.2.021103
Stefaniotou M., Tranos P., Kotsolis A., et al. Central serous chorioretinopathy after corticosteroid therapy for myasthenia gravis: treatment with argon laser photocoagulation // Case Rep Ophthalmol. — 2013. — Vol. 4, No. 2. — P. 112–117. https://doi.org/10.1159/000351440
Huang H., Zhang L., et al. Low-level laser therapy in experimental autoimmune myasthenia gravis: mitochondrial modulation // Neural Regen Res. — 2016. — Vol. 11, No. 30. — P. 1898–1905. https://doi.org/10.4103/1673-5374.193237
Gupta A., Dai T., Hamblin M.R. Effect of red and near-infrared wavelengths on low-level laser (light) therapy-induced healing of partial-thickness dermal abrasion // Lasers Surg Med. — 2014. — Vol. 46. — P. 89–97. https://doi.org/10.1002/lsm.22191
Khan I., Arany P.R. Photobiomodulation therapy for tissue healing: pathophysiology and mechanisms // J Dent Res. — 2015. — Vol. 94, No. 9. — P. 1177–1186. https://doi.org/10.1177/0022034515593597
Chung H., Dai T., Sharma S.K., et al. The nuts and bolts of low-level laser (light) therapy // Ann Biomed Eng. — 2012. — Vol. 40, No. 2. — P. 516–533. https://doi.org/10.1007/s10439-011-0454-7
Lopes-Martins R.A., Marcos R.L., et al. Photobiomodulation and sports medicine: a new therapeutic approach for performance and recovery // Br J Sports Med. — 2018. — Vol. 52, No. 10. — P. 595–596. https://doi.org/10.1136/bjsports-2017-098272
Bicknell B., Liebert A., Kiat H. Neuroprotective mechanisms of photobiomodulation: evidence from pre-clinical and clinical studies // Mol Neurobiol. — 2021. — Vol. 58, No. 5. — P. 2237–2259. https://doi.org/10.1007/s12035-020-02267-4
